[Probability of control of the patient with diabetes exclusively treated with pharmacological therapy]
- PMID: 16904032
[Probability of control of the patient with diabetes exclusively treated with pharmacological therapy]
Abstract
Objective: to predict the probability of blood glucose control in patients with type-2 diabetes mellitus, exclusively treated with pharmacology therapy.
Material and methods: secondary analysis of a database to evaluate the therapeutic attachment in type-2 diabetics older than 60 years old. We interviewed 123 patients in their home to get information about sociodemographic aspects and diabetes characteristics. The blood glucose control was measured through glycated hemoglobin and the attachment to the pharmacological treatment was measured by the Morisky-Green test. The analysis included simple logistic regression; the calculation of probability of control for different levels of therapeutic attachment was estimated using the result of the regression equation (y) and applying the formula 1/1 + e(-y).
Results: Monotherapy was present in 82.1%, glibenclamide was prescribed alone in 77.2%, glycated hemoglobin average was 11.5 +/- 3.5 %, 18% of the population was controlled and 58.1% showed some attachment to the pharmacological treatment. With a total attachment to the pharmacological prescription, the control probability is 27%, and without it, it corresponds to 10%.
Conclusion: Almost three out of ten patients with a total attachment to the pharmacological treatment have chances of being controlled.
Similar articles
-
[Insulin, glibenclamide plus acarbose in diabetes mellitus?].Dtsch Med Wochenschr. 1995 Nov 17;120(46):1605. Dtsch Med Wochenschr. 1995. PMID: 7588044 German. No abstract available.
-
Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.J Med Assoc Thai. 1995 Nov;78(11):578-85. J Med Assoc Thai. 1995. PMID: 8576667 Clinical Trial.
-
Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.Arch Intern Med. 1997 Apr 28;157(8):836-48. Arch Intern Med. 1997. PMID: 9129543 Review.
-
Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.Med Sci Monit. 2003 Jun;9(6):CR240-3. Med Sci Monit. 2003. PMID: 12824953
-
The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):373-9. doi: 10.1016/j.numecd.2007.04.003. Epub 2007 Oct 24. Nutr Metab Cardiovasc Dis. 2008. PMID: 17919894 Clinical Trial.
Cited by
-
Application of machine learning methodology to assess the performance of DIABETIMSS program for patients with type 2 diabetes in family medicine clinics in Mexico.BMC Med Inform Decis Mak. 2019 Nov 12;19(1):221. doi: 10.1186/s12911-019-0950-5. BMC Med Inform Decis Mak. 2019. PMID: 31718638 Free PMC article.
-
[Effectiveness of interventions for improving drug prescribing in Primary Health Care].Aten Primaria. 2017 Jan;49(1):13-20. doi: 10.1016/j.aprim.2016.02.006. Epub 2016 Jun 11. Aten Primaria. 2017. PMID: 27296077 Free PMC article. Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical